Cyclosporine versus tacrolimus (FK 506) for prevention of cardiac allograft vasculopathy. This study prospectively compared the impact of cyclosporine A and tacrolimus on the development of cardiac allograft vasculopathy. By using serial intravascular ultrasound examinations, a trend toward a more pronounced progression was noted in the tacrolimus group in the first year after heart transplantation. 